Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
JD Health International, Inc. ( (HK:6618) ) has provided an update.
JD Health International, Inc. has announced its upcoming annual general meeting scheduled for June 20, 2025, in Beijing, China. Key agenda items include the adoption of the company’s financial statements for 2024, re-election of several directors, and re-appointment of Deloitte Touche Tohmatsu as auditors. The meeting will also consider granting the board authority to manage share allotments, reflecting the company’s strategic focus on maintaining robust governance and operational flexibility.
More about JD Health International, Inc.
JD Health International, Inc. operates in the healthcare industry, providing a range of health-related services and products. The company focuses on leveraging technology to offer online medical consultations, pharmaceutical retail, and health management services, primarily targeting the Chinese market.
YTD Price Performance: 27.94%
Average Trading Volume: 22,284,152
Technical Sentiment Signal: Sell
Current Market Cap: HK$115B
Find detailed analytics on 6618 stock on TipRanks’ Stock Analysis page.